Exam (elaborations)
NR546 Week 5 test your knowledge questions with complete solutions.
NR546 Week 5 test your knowledge questions with complete solutions.
[Show more]
Preview 4 out of 31 pages
Uploaded on
September 6, 2024
Number of pages
31
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
NR546
Course
NR546
$12.99
Also available in package deal from $69.04
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (1)
$ 166.87
$ 69.04
13 items
1. Exam (elaborations) - Nr546 week 3 exam with correct answers.
2. Exam (elaborations) - Nr546 week 2 test your knowledge questions with correct answers
3. Exam (elaborations) - Week 8 nr 546 exam with correct answers.
4. Exam (elaborations) - Nr 546 final exam, week 7 reproductive questions with complete solutions
5. Exam (elaborations) - Nr546 week 3 test your knowledge questions with correct answers.
6. Exam (elaborations) - Nr546 week 6 test your knowledge questions with correct answers
7. Exam (elaborations) - Nr546 week 5 test your knowledge questions with complete solutions.
8. Exam (elaborations) - Nr546 week 7 test your knowledge questions with correct answers
9. Exam (elaborations) - Nr546 week 1- test your knowledge questions with correct answers
10. Exam (elaborations) - Nr546 midterm exam with correct answers.
11. Exam (elaborations) - Nr547 final exam with correct answers
12. Exam (elaborations) - Nr546 psychopharm midterm exam with complete solutions
13. Exam (elaborations) - Nr 546 exam with correct answers
Show more
NR546 Week 5 test your knowledge questions
with complete solutions
Pharmacologic |Treatment |of |Major |Depressive |Disorder |- |correct |answer-Selective |serotonin |
reuptake |inhibitors |(SSRIs)
Serotonin-norepinephrine |reuptake |inhibitors |(SNRIs)
Norepinephrine |and |dopamine |reuptake |inhibitors |(NDRIs)
Serotonin |antagonists |and |reuptake |inhibitors |(SARIs)
Miscellaneous |antidepressants
Monoamine |oxidase |(MAO)-B |inhibitors
Adjunct: |antipsychotics
Pharmacologic |Treatment |of |Bipolar |Disorder |- |correct |answer-Lithium
Anticonvulsants
Second |generation |antipsychotics
Mood |disorders: |role |of |the |psychiatric |mental |health |nurse |practitioner |(PMHNP) |is |to: |- |
correct |answer-determine |the |malfunctioning |brain |circuit |responsible |for |the |client's |
presenting |symptoms |and |select |the |appropriate |medication |that |targets |the |associated |
neurotransmitter(s)
Mood |disorders |manifest |across |a |spectrum |from: |- |correct |answer-mania |to |major |depressive
|disorder |(MDD)
Unipolar |depression |- |correct |answer-major |depressive |disorder |(MDD)
one |of |the |most |common |mental |disorders
,-Approximately |7.1% |of |adults |in |the |U.S. |had |episode |in |last |year, |prevalence |highest |(13.1%) |
among |individuals |aged |18-25
S/S
-depressed |mood
-loss |of |interest |or |pleasure |in |daily |activities
-irritability
-withdrawal
-problems |with |sleep, |eating, |energy, |concentration, |or |self-worth
-severe |depression: |may |experience |thoughts |of |suicide |or |psychotic |symptoms.
Bipolar |disorder |(BD) |- |correct |answer-Chronic |condition |characterized |by |extreme |
fluctuations |in |mood, |energy, |and |ability |to |function
-Moods |may |be |manic, |hypomanic, |or |depressed |and |may |include |mixed |mood |or |psychotic |
features
-many |have |only |experienced |only |one |manic |episode |in |their |lifetime
-Mood |fluctuations |may |be |separated |by |periods |of |high |stability |or |may |cycle |rapidly
-diagnosed |when |a |client |has |one |or |more |episodes |of |mania |or |hypomania |with |a |history |of |
one |or |more |major |depressive |episodes
-high |risk |for |suicide
mania |- |correct |answer-characterized |by |a |persistently |elevated, |expansive, |or |irritable |mood. |
Related |symptoms |may |include |inflated |self-esteem, |increased |goal-directed |activity |or |
energy, |including |grandiosity, |decreased |need |for |sleep, |excessive |talkativeness, |racing |
thoughts, |flight |of |ideas |(FOI), |distractibility, |psychomotor |agitation, |and |a |propensity |to |be |
involved |in |high-risk |activities. |Mania |leads |to |significant |functional |impairment |and |may |
include |psychotic |features |or |necessitate |hospitalization
Bipolar |Type |I: |- |correct |answer-requires |at |least |one |episode |of |mania |for |at |least |one |week |
(or |any |duration |if |hospitalization |due |to |symptoms |is |required)
,Bipolar |Type |II: |- |correct |answer-diagnosis |requires |a |current |or |past |hypomanic |episode |and |
a |current |or |past |major |depressive |episode. |Symptoms |last |for |at |least |4 |days |but |fewer |than |
seven. |
-Hypomanic |symptoms |are |not |of |sufficient |duration |or |severity |to |cause |significant |
functional |impairment, |psychosis, |or |hospitalization. |
-Anger |and |irritability |are |common. |
-Clients |often |enjoy |the |elevation |of |mood |and |are |reluctant |to |report |these |symptoms, |
making |bipolar |more |difficult |to |diagnose |if |the |client |presents |in |the |depression |phase.
Cyclothymia: |- |correct |answer-involves |the |chronic |presentation |of |hypomanic |and |
depressive |symptoms |that |do |not |meet |the |diagnostic |criteria |for |a |major |depressive |or |
manic/hypomanic |episode.
If |bipolar |depression |is |mistaken |for |MDD: |- |correct |answer-antidepressant |therapy |may |
precipitate |a |manic |episode |or |induce |rapid-cycling |bipolar |depression
-may |contribute |to |the |increased |incidence |of |death |by |suicide |in |children |and |adults |younger
|than |25
Antidepressants |are |used |cautiously |in |clients |with |bipolar |disorder |and |never |as |
________________. |- |correct |answer-monotherapy
-Antidepressants |should |be |combined |with |a |mood |stabilizer |to |prevent |the |onset |of |a |
hypomanic |or |manic |episode
DA, |NE |Dysfunction |causes |what |mood |related |symptoms |- |correct |answer-Decreased |
positive |affect:
depressed |mood
loss |of |joy
lack |of |interest
loss |of |energy
, decreased |alertness
decreased |self-confidence
appetite |changes
5HT, |NE |Dysfunction |causes |what |mood |related |symptoms |- |correct |answer-Increased |
negative |affect:
depressed |mood
guilt
fear/anxiety
hostility
irritability
loneliness
appetite |changes
neurobiological |factors |that |contribute |to |mood |and |mood |disorders: |Genetics |- |correct |
answer-MDD |and |BD |are |heritable |disorders
-genetic |factors |31-42% |of |the |disease |risk |in |MDD |and |59-85% |in |BD
-causes |of |mood |disorders |complex, |likely |involve |interactions |between |genetic/epigenetic, |
biological, |psychological, |and |social |factors |including:
• |dysfunctions |in |brain
• |imbalance |of |neurotransmitters
• |life |events
• |abuse |or |trauma
• |substance |use |or |medication
• |menstruation
• |season |changes